Have questions about the economic measures put in place to support businesses affected by the coronavirus (COVID-19)? Visit the Québec.ca
website.
Have questions about the economic measures put in place to support businesses affected by the coronavirus (COVID-19)? Visit the Québec.ca website.
La page est en cours de chargement... 
Québec’s many strengths allow it to stand out on the international stage in a number of fields, such as:
It also excels in two cross-cutting niches:
Here are examples of recent discoveries made in Québec that will revolutionize the medicine of tomorrow in many areas:
Discovery of a new heart and bowel disease
Pediatric cardiologists and researchers at CHU de Québec* and CHU Sainte-Justine have discovered a new disease.
Known as chronic atrial and intestinal dysrhythmia (CAID), this rare disease disrupts the electrical system of muscle cells regulating heart and bowel functions.
*In French only.
Doctor Daniel Kaufmann and his team, affiliated with Centre de recherche du Centre hospitalier de l’Université de Montréal, have developed a technique to accurately target HIV reservoirs, including CD4 lymphocytes harbouring dormant HIV. With this breakthrough, we may be able to develop drugs to treat infected cells.
*In French only.
Major clinical breakthrough
Researchers at Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) unveiled the results of a clinical study demonstrating equivalency between cyclotron-produced technetium (Tc-99m) and that produced in a nuclear reactor.
Discovery of a small molecule could improve treatment response in depressed patients
Researchers at the Douglas Mental Health University Institute have found that levels of a tiny molecule, miR-1202, are lower in the brains of depressed individuals.
This discovery may hold a key to improving treatment options for those who suffer from depression and help detect individuals who are likely to respond to antidepressant treatment.
World breakthrough: a new molecule allows for an increase in stem cell transplants
Researchers at Université de Montréal’s Institute for Research in Immunology and Cancer have discovered a new molecule, UM171, that could multiply by more than 10 the number of cord blood units available for human stem cell transplants.
A new cognitive training system
The NeuroTracker is a cognitive training system developed at Dr. Jocelyn Faubert’s optometry and psychophysics laboratory at Université de Montréal. Commercialized since 2009, the system recreates game environments to help athletes better divide their attention and improve their vision.
Characterization of the impact of gene mutations BRCA1 and BRCA2
Dr. Jacques Simard was involved in characterizing the impact of mutations BRCA1 and BRCA2 in breast and ovarian cancer susceptibility genes. Identifying these gene mutations allows women who are carriers to make important health-related decisions that can lead to more active preventive measures (e.g., screening, preventive surgery/chemotherapy).
Jacques de Guise and his team, in collaboration with EOS Imaging and Arts et Métiers ParisTech, have developed biplanar (front and side) X-ray technology for creating 3D bone and skeleton models.
The Government of Québec supports many organizations in order to promote innovative and promising university research projects.
The purpose of Québec’s three commercialization companies is to bring to market technologies based on conclusive research conducted at universities, affiliated research centres and university hospitals.
Here are Québec’s three commercialization companies:
(Université du Québec, Concordia University, McGill University, Bishop’s University and Université de Sherbrooke) (Université Laval) (Université de Montréal)Québec is currently investing over $25 billion to modernize its research and healthcare facilities. Four new hospitals will be built with these funds:
Three world-class research centres were also built with $905 million in funding:
Over 125,000 m2 will be dedicated to research.
For a full list of public research facilities: Public research facilities directory
* (BCLQ) (CR-IUCPQ) Biobank (CARTaGENE, ECOGENE 21) *In French only.
